This study describes the expression of PAC1 and VPAC1 receptor (PAC1-R and VPAC1-R) mRNAs in the brain of frog (Rana esculenta) during development. PAC1-R mRNA was detected in the periventricular and subependymal layers of the thalamus and epithalamus and in the ependymal layer of the mesencephalon and rhombencephalon (stage 20), in the amygdala, in the habenular complex, in the periventricular nucleus of the hypothalamus, and in the ventral cerebellum (stage 30). VPAC1-R mRNA expression was observed only at stage 20, in the floor of the hypothalamus. These results suggest that, in amphibians, pituitary adenylate cyclase-activating polypeptide (PACAP) may play a role in brain development
International audienceThe biochemical characteristics and the distribution of pituitary adenylate cy...
International audienceThe primary structure of frog pituitary adenylate cyclase-activating polypepti...
International audienceThe primary structure of frog pituitary adenylate cyclase-activating polypepti...
This study describes the expression of PAC1 and VPAC1 receptor (PAC1-R and VPAC1-R) mRNAs in the bra...
The anatomic distribution and biochemical characteristics of the neuropeptide pituitary adenylate cy...
The anatomic distribution and biochemical characteristics of the neuropeptide pituitary adenylate cy...
The anatomic distribution and biochemical characteristics of the neuropeptide pituitary adenylate cy...
International audienceThe anatomic distribution and biochemical characteristics of the neuropeptide ...
The anatomic distribution and biochemical characteristics of the neuropeptide pituitary adenylate cy...
International audienceThe anatomic distribution and biochemical characteristics of the neuropeptide ...
Pituitary adenylate cyclase-activating polypeptide (PACAP), a novel peptide of the secretin/glucagon...
International audienceThe anatomic distribution and biochemical characteristics of the neuropeptide ...
International audiencePituitary adenylate cyclase-activating polypeptide (PACAP), a novel peptide of...
International audiencePituitary adenylate cyclase-activating polypeptide (PACAP), a novel peptide of...
International audienceThe biochemical characteristics and the distribution of pituitary adenylate cy...
International audienceThe biochemical characteristics and the distribution of pituitary adenylate cy...
International audienceThe primary structure of frog pituitary adenylate cyclase-activating polypepti...
International audienceThe primary structure of frog pituitary adenylate cyclase-activating polypepti...
This study describes the expression of PAC1 and VPAC1 receptor (PAC1-R and VPAC1-R) mRNAs in the bra...
The anatomic distribution and biochemical characteristics of the neuropeptide pituitary adenylate cy...
The anatomic distribution and biochemical characteristics of the neuropeptide pituitary adenylate cy...
The anatomic distribution and biochemical characteristics of the neuropeptide pituitary adenylate cy...
International audienceThe anatomic distribution and biochemical characteristics of the neuropeptide ...
The anatomic distribution and biochemical characteristics of the neuropeptide pituitary adenylate cy...
International audienceThe anatomic distribution and biochemical characteristics of the neuropeptide ...
Pituitary adenylate cyclase-activating polypeptide (PACAP), a novel peptide of the secretin/glucagon...
International audienceThe anatomic distribution and biochemical characteristics of the neuropeptide ...
International audiencePituitary adenylate cyclase-activating polypeptide (PACAP), a novel peptide of...
International audiencePituitary adenylate cyclase-activating polypeptide (PACAP), a novel peptide of...
International audienceThe biochemical characteristics and the distribution of pituitary adenylate cy...
International audienceThe biochemical characteristics and the distribution of pituitary adenylate cy...
International audienceThe primary structure of frog pituitary adenylate cyclase-activating polypepti...
International audienceThe primary structure of frog pituitary adenylate cyclase-activating polypepti...